Xxxxxxxx xx 31.3.2006 xx 22.9.2007 (do xxxxxx č. 230/2007 Xx.)
Xxxxxxx x. 6 x vyhlášce č. 26/2001 Xx.
Xxxx 1
Xxxxxx xxxxxxxxxxxxx xxxxxx povolených x xxxxxxxxxxxx xxxxxxxxxxxx, xxxxxxxx přípustné koncentrace, xxxxxxxxx xx xxxxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxx x xxxxxxxx xxxxxxx
Xx xxxxxxxxxxx xxxxxxx xx xxxxxxxx i xxxx xxxxx, xxxxxxxxx x xxxxxxx č. 6. x to xxxx xxxxxxxx, sodné, xxxxxxxx, xxxxxxxxx, amonné, xxxxxxxxxxxxxx x xxxx xxxxxxxx, xxxxxxx, sírany, octany x xxxxxx-, ethyl-, xxxxxx, xxxxxxxxx-, xxxxx-, xxxxxxxx- x xxxxxxxxxxx.
Xxxxx xxxxxxxx xxxxxxxx (+) xxx xxxxxxxx do xxxxxxxxxxxx prostředku xxxxxx x xxxxxxxxxxx xxxx, xxx xx x xxxxxxx x. 6 xxxxxxx, xxx xxx xxx specifické xxxxx, xxxxx xxxx zřejmé x xxxxxxxxxxx xxxxxx, xxxxxxxx účelu použití xxxxxxxxxxxx prostředku, například xxxx xxxxxxxxxxx xx xxxxx xxxx přísady xxxxx xxxxx xx xxxxxxx.
Xxxxxxx xxxxx xxxxxxxxx xx xxxxxxxxx xxxxxxxxxxxx xxxxxxxxxx xxxxx xxx xxxxxx xxxxxxxxxxxxxxx vlastnosti x xxxxx xxx xxxxxxxxx xxxxxxxxxx xxxxxxx. Xxx xxxxxxxxx o xxxx xxxxxxxxxx olejů x xxxxxxx xxxxxxxx. Xxxx xxxxx xxxxxx xxxxxxxx xx xxxxxxx x. 6.
Xxxxxxx xxxxxxx xxxxxxxxxx xxxxxxxxxx, xxxxx xxxxxxxx formaldehyd nebo xxxxx xxxxxxxxxxx xxxxxxxxxx, xxxx xxx xx xxxxx označeny xxxxxxxxx "xxxxxxxx formaldehyd", xxxxx xxxxxxxxxxx xxxxxxxxxxxx xx xxxxxxxx xxxxxxx xxxxxxxx 0,05 xxxxxxx.
___________________________________________________________________________________________
Xxx. Xxxxx Xxxxxxxxx Xxxxxxx x xxxxxxxxx Xxxxxxxx použití
číslo povolená xxxxxxxxxxx x xxxxxxxx, xxxxx xxxx
xxx xxxxxxxxx xx xxxxx
___________________________________________________________________________________________
x b c x e
___________________________________________________________________________________________
1 Xxxxxxxx benzoová•; 0,5 % x xxxxxxxx xx kyselinu
/Benzoic acid/°, xxxx xxxx
x xxxxxx (+)
___________________________________________________________________________________________
2 Xxxxxxxx xxxxxxxxxx•; 2 % x přepočtu xx kyselinu
/Propionic acid/°a xxxx soli
___________________________________________________________________________________________
3 Kyselina salicilová•; 0,5 % x xxxxxxxx xx xxxxxxxx Xxxxx xxx použito xx xxxxxxx pro Nepoužívat pro xxxx
/Xxxxxxxxx xxxx /°x xxxx xxxx do 3 let x xxxxxxxx xxxxxxx. xx 3 xxx (1).
xxxx (+)
___________________________________________________________________________________________
4 Xxxxxxxx xxxxxxx (hexa- 0,6 % x přepočtu na xxxxxxxx
-2,4-xxxxxxx xxxxxxxx)•;
/Xxxxxx acid (xxxx-2,4-
-xxxxxxx xxxx)/°x xxxx
xxxx (+)
___________________________________________________________________________________________
5 Xxxxxxxxxxx•; 0,2 % (xxxx xxxxxxxxxx pro Xxxxxxxx v rozprašovačích
/Formaldehyde/°a xxxxxxx úst) aerosolů (xxxxxxxx).
xxxxxxxxxxxxxxx• ; 0,1 % (xxxxxxxxxx pro xxxxxxx
/Xxxxxxxxxxxxxxxx/°(+) xxx) x xxxxxxxx xx xxxxx
xxxxxxxxxxx
___________________________________________________________________________________________
6 xxxxxxx neobsazena
___________________________________________________________________________________________
7 Xxxxxxx.-2-xx(x-xxxxx- 0,2 % x přepočtu xx xxxxx
xxxxx)•; /Xxxxxxxx-2-
-xx(x-xxxxxxxxxxxx/°)
x xxxx xxxx (+)
___________________________________________________________________________________________
8 Pyrithion xxxxxxxxx• 0,5 % Povolen xxx xxx xxxxxxxxxx,
/Xxxxxxxxxx xxxx/* (+) xxxxx se xxxxxxxxx. Xxxxxxx
x xxxxxxxxxxxx xxxxx xxxxxxx.
___________________________________________________________________________________________
9 Anorganické siřičitany 0,2 % v xxxxxxxx xx volný XX2
x xxxxxxxxxxxxxxxxxx
/Xxxxxxxxx xxxxxxxxx xxx
xxxxxxxxxxxxxxxxx/°(+)
___________________________________________________________________________________________
10 Xxxxxxxx xxxxx 0,1 % Xxx xxx prostředky, xxxxx
/Xxxxxx iodate/° se xxxxxxxxx.
___________________________________________________________________________________________
11 Xxxxxxxxxxxx• 0,5 % Xxxxxxxx v xxxxxxxxxxxxxx Xxxxxxxx
/Xxxxxxxxxxxx/* xxxxxxxx (xxxxxxxx). xxxxxxxxxxxx.
___________________________________________________________________________________________
12 Xxxxxxxx 4- 0,4 % xxxx xxxxxxxx xxx xxxxx
-xxxxxxxxxxxxxxx•; xxxxx
/4-Xxxxxxxxxxxxxx 0,8 % jako xxxxxxxx pro xxxx
xxxx/°x xxxx soli x xxxxxx
xxxxxx (+)
___________________________________________________________________________________________
13 3-Xxxxxx-6-xxxxxx-2,3- 0,6 % x přepočtu xx xxxxxxxx Xxxxxxxx v xxxxxxxxxxxxxx
-xxxxxxx-4X-xxxxx-2,4- xxxxxxxx (sprejích).
-dion•; /Xxxxxx-6-xxxxxx-
-xxxxx-2,4(3X)-xxxxx
(Xxxxxxxxxxxxx xxxx)/°
x xxxx soli
___________________________________________________________________________________________
14 Xxxxxxxx xxxxxxxx•; 0,5 x xxxxxxxx xx xxxxxxxx
/Xxxxxx xxxx/°x xxxx
xxxxx xxx/ (+)
___________________________________________________________________________________________
15 3,3´-Xxxxxx-4,4´- 0,1%
(xxxxx-1,6-xxxxxxxxx)
xxxxxxxxxxxxxx•
(Xxxxxxxxxxxxxxx);
/3,3´-Xxxxxxx-4,4´-
-xxxxxxxxxxxxxxxxxx-
xxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxx/°
x xxxx xxxx xxxxxx
xxxxxxxxxxx•
/xxxxxxxxxxx/°(2-xxxxx-
xxxxxxx-1-xxxxxxxxx)•
___________________________________________________________________________________________
16 Xxxxxxxxxx• /Xxxxxxxxxx/* 0,007 % (xxxx Hg) xx xxxxx x Pouze xxx prostředky x xxxxxx Xxxxxxxx thiomersal.
ostatními xxxxxxxxxxxx xxxxx x odličování xxx.
xxxxxxxxxx touto xxxxxxxxx
xxxxxxx xxxxxxxxx xxxxxxxx
xxxxxxxxxxx 0,007 % Xx
___________________________________________________________________________________________
17 Xxxxxxxxxxxxx xxxx• 0,007 % (xxxx Xx) xx xxxxx x Xxxxx xxx xxxxxxxxxx x xxxxxx Xxxxxxxx
(xxxxxx borátu) xxxxxxxxx xxxxxxxxxxxx rtuti a xxxxxxxxxx xxxxx očí. fenylrtuťnaté
/Phenylmercuric xxxxx xxxxxxxxxx xxxxx vyhláškou xxxxxxxxxx.
(xxxxxxxxx xxxxxx)/° xxxxxxx xxxxxxxxx xxxxxxxx
xxxxxxxxxxx 0,007 % x Hg
___________________________________________________________________________________________
18 Kyselina xxxx-10-xxxxx•; 0,2 % x xxxxxxxx xx kyselinu
/Undec-10-enoic xxxx/°
x xxxx xxxx(+)
___________________________________________________________________________________________
19 Xxxxxxxxx 0,1 %
/Xxxxxxxxxx/* (+)
___________________________________________________________________________________________
20 5-brom-5-nitro-1,3-dioxan 0,1 % Xxx xx xxxxxxxxxx, xxxxx xx
(Xxxxxxxx)• /5-Bromo-5- oplachují.
-nitro-1,3-dioxane/° Zamezit xxxxxx nitrosaminů.
___________________________________________________________________________________________
21 Xxxxxxxx /Xxxxxxxx/* (+) 0,1 % Xxxxxxx tvorbě xxxxxxxxxxx.
___________________________________________________________________________________________
22 2,4-Xxxxxxx-xxxxxx- 0,15 %
xxxxxxx• /2,4-Xxxxxxxx-
xxxxxx xxxxxxx/°(+)
___________________________________________________________________________________________
23 Xxxxxxxxxxxx 0,2 % Xxxxxxxx xxxxxxx: 3,3´,4,4´-
/Xxxxxxxxxxxx/* (+) xxxxxxxxxxxxxxxxxxx xxxx xxx 1
xxx 3,3´,4,4´-xxxxxxxxxxxxxxx-
xxxxxx xxxx xxx 1 xxx
___________________________________________________________________________________________
24 4-Xxxxx-x-xxxxxx• 0,2% Zakázán v xxxxxxxxxxxx
/4-Xxxxxx-x-xxxxxx/°(+) xxxxxxxxxxxxxx xx kontaktu
se xxxxxxxx.
___________________________________________________________________________________________
25. Xxxxxxxxx /Xxxxxxxxx/* (+) 0,3 %
___________________________________________________________________________________________
26 4-Xxxxx-3,5-xxxxxxx(4- 0,5 %
-xxxxx-3,5-xxxxxxxxxxxxx)•
/4-Xxxxxx-3,5-xxxxxxx/°(+)
___________________________________________________________________________________________
27 3,3´-Xxx[1-(xxxxxxx- 0,6 %
xxxxxx)-2,5-xxxxxxxxxx-
xxxxxxx-4-xx]-1,1´-
xxxxxxxxxxxxxxxxxx
(xxxxxxxxxxxxxxxxxxxxxx)•
/3,3´--Xxx(1-xxxxxxx-
xxxxxx-2,5-xxxxxxxxxx-
xxxxxxx-4-xx)-1,1´-xxxxxx-
xxx-xxxxx ("Xxxxxxxxxxxxxx
xxxx") /°(+)
___________________________________________________________________________________________
28 Poly-1-hexamethylen 0,3 %
biguanid-hydrochlorid•
/Poly-(1-hexamethyl-
enbiguanide xxxxx-
xxxxxxxx/°(+)
___________________________________________________________________________________________
29 2-Xxxxxxxxxxx-1-xx• 1 %
/2-Xxxxxxxxxxxxxx/°(+)
___________________________________________________________________________________________
30 Xxxxxxxxxxxxxxxxxxxx 0,15 %
(methenamin, xxxxxxxxx)•
/Xxxxxxxxxxxxxxxxxxxxx
(xxxxxxxxxxx*)/°(+)
___________________________________________________________________________________________
31 Xxxxxxxxxx-3-xxxxxx- 0,2 %
-xxxxxxxxxxxx•
/Xxxxxxxxxxx-3-xxxxxx-
xxxxxxxxxxxxx/°(XXXX)
___________________________________________________________________________________________
32 1-(4-Chlorfenoxy)-1- 0,5 %
(xxxxxxxx-1-xx)-3,3´-
xxxxxxxxxxxxx-2-xx•
/1-(4-Xxxxxxxxxxxxx)-
-1-(xxxxxxxx-1-xx)3,3-
-xxxxxxxxxxxxx-2xxx/°
(+)
___________________________________________________________________________________________
33 1,3-Bis(hydroxymethyl)- 0,6 %
-5,5-xxxxxxxxxxxxxxxxxxxx-
2,4-xxxx• /1,3-Bis
(hydroxy-methyl)-5,5-
-dimethyl-imidazolidine-
-2,4-dione/°(+)
___________________________________________________________________________________________
34 Xxxxxxxxxxxxx• 1 %
/Xxxxxx alcohol/°
___________________________________________________________________________________________
35 1-Hydroxy-4-methyl-6- 1 % Xxx xxxxxxxxxx, které se xxxxxxxxx.
(2,4,4-xxxxxxxxxxxxxxx)
xxxxxxx-2(1X)-xx•;
/1-Xxxxxxx-4-xxxxxx-6 0,5 % Pro xxxxxxx xxxxxxxxxx.
(2,4,4-xxxxxxxxx-xxxxxx)
2-xxxxxxx/°x xxxx
xxxxxxx x xxxxxxxxxx-
xxxxxxx• (octopirox) (+)
___________________________________________________________________________________________
36 1,2-Xxxxxx-2,4- 0,1 % Xxxxx xxx xxxxxxxxxx, xxxxx
xxxxxxxxxxx• xx xxxxxxxxx.
/1,2-Xxxxxxx-2,4-
-xxxxxxxxxxxxx°
XXXXXXXXXXXXX
XXXXXXXXXXXXXX•
___________________________________________________________________________________________
37 6,6´-Xxxxxx-4,4-´xxxxxxx- 0,1 %
-2,2-´xxxxxxxxxxxxxxx•
(Xxxxxxxxxxxxxx)
/6,6-Xxxxxxx-4,4-xxxxxxxx-
2,2-´xxxxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxx)/°(+)
___________________________________________________________________________________________
38 4-Xxxxxxxxx-x-xxxxxx 0,1 %
(4-xxxxxxxxx-3-xxxxxxxxxxx)•
/4-Xxxxxxxxx-x-xxxxxx/°
___________________________________________________________________________________________
39 Xxxx 5-chlor-2-methyl- 0,0015 % (Xxxx x xxxxxx 3 :1
-isothiazol-3(2H)-onu• 5-xxxxx-2-xxxxxx-xxxxxxxxxx-3(2X)-
/5-xxxxxx-2-xxxxxxx- -xx a 2-xxxxxxxxxxxxxxxx-3(2X)-xx
xxxxxxxxx-3(2X)-xxx/°x
2-xxxxxxxxxxxxxxxx-3(2X)-
-xxx• /2-xxxxxxxxxxxxxxxx-
3(2X)-xxx/°x chloridem
hořečnatým /xxxxxxxxx
xxxxxxxx/°x xxxxxxxxxx
xxxxxxxxxx /xxxxxxxxx
xxxxxxx/°
___________________________________________________________________________________________
40 2-Benzyl-4-chlorfenol• 0,2 %
(Xxxxxxxxx) /2-Xxxxxx-4-
-xxxxxxxxxxx
(Xxxxxxxxxxx)/°
___________________________________________________________________________________________
41 Xxxxxxxxxxxxx• 0,3 % Xxxxxxxx
/2-Xxxxxxxxxxxxxx/° xxxxxxxxxxxxx.
___________________________________________________________________________________________
42 Xxxxxxxxxxxx• 0,3 % x xxxxxxxx na xxxxxxxxxxxx
/Xxxxxxxxxxxxx/* x xxxx
xxxxxxxxxx, /xxxxxxxxxxx/°,
xxxxxxxx /xxxxxxxxx/ x
xxxxxxxxxxxxxx
/xxxxxxxxxxxxxxx/°(+)
___________________________________________________________________________________________
43 1-Fenoxypropan-2-ol• 1,0 % Xxx pro xxxxxxxxxx, xxxxx se
/1-Phenoxypropan-2-ol/° oplachují.
___________________________________________________________________________________________
44 Xxxxx (X12 - X22) 0,1 %
xxxxxxxxxxxxxxxxxxxxxx
x -chlorid•
/Alkyl (X12 - C22) trimethyl
ammonium-bromide
a xxxxxxxx/°(+)
___________________________________________________________________________________________
45 4,4-Xxxxxxxx-1,3- 0,1 % xX xxxxxxxxx xxxxxxxx xxxxx
-xxxxxxxxxx• /4,4-Di- být xxxxx xxx 6.
methyl-1,3-oxazolidine/
___________________________________________________________________________________________
46 1-[1,3-Bis(hydroxy- 0,5 %
-xxxxxx)-2,5-xxxxx-
xxxxxxxxxxxx-4-xx]-1,3-
-xxx(xxxxxxxxxxxxx)
xxxxxxxx•
/X-(Xxxxxxxxxxxxx)-X-
-(xxxxxxxxxxxxxxx-1,3-
-xxxxx-2,5-xxxxxxxxxxx-
xxx-4)X´-(xxxxxxx-
xxxxxx)xxxx/
___________________________________________________________________________________________
47 4,4-´(Xxxxx-1,6-xxxxxx- 0,1 %
xxx)xxxxxxxxxxxxxx•
/1,6-Xx(4-xxxxxxxxxxxx-
xx)-x-xxxxxx(Xxxxxxxx-
xx)/°x xxxx xxxx xxxxxx
xxxxxxxxxxx (2-hydroxy-
-ethan-1-sulfonátu)•
/isethionate/°a 4-hydro-
xybenzoátu• /x-xxxxx-
xxxxxxxxxx/°(+)
___________________________________________________________________________________________
48 Xxxxxxxxxxxxxx 0,1 % Zakázáno x xxxxxxxxxxxxxx Xxxxxxxx
(xxxxxxxxxx)• xxxxxxxx (xxxxxxxx). xxxxxxxxxxxxx.
/Xxxxxxxxxxxxx (xxx xxxxxx
(Xxxxxxx-1,5-xxxx)/° xxxxxxxxxxxxxx x
xxxxxxxx xxxxxxxx
xxxxxx než 0,05 %)
___________________________________________________________________________________________
49 5-Ethyl-3,7-dioxa-1- 0,3 % Xxxxxxx x xxxxxxxxxxxx xxxxx
-xxxxxxxxxx[3.3.0]xxxxx• xxxxxxx x x xxxxxxxxxxxx
/5-Xxxxx-3,7-xxxxx-1- xxxxxxxxxxxxxx xx xxxxxxxx
-xxxxxxxxxx[3.3.0] xx xxxxxxxx.
xxxxxx/°
___________________________________________________________________________________________
50 3-(4-Xxxxxxxxxxx)-xxxxxx- 0,3 %
-1,2diol• (Xxxxxxxxxxxx)
/3-(x-Xxxxxxxxxxxx)-
-xxxxxxx-1,2-xxxx
(Xxxxxxxxxxxxx)/°
___________________________________________________________________________________________
51 [(Xxxxxxxxxxxxx)xxxxx] 0,5 %
xxxxxx xxxxx, X-(xxxxxxx-
xxxxxx)-xxxxxxxx sodný,•
/Sodium xxxxxxxxxxxxxx-
xxxxxxxxxxx, (Xxxxxx
xxxxxxxxxxxxxxxxxxxxxx)/°
___________________________________________________________________________________________
52 Xxxxxxx xxxxxxxx xxxxx- 0,004 % x xxxxxxxx xx AgCl 20 % (hmotn.)AgCl na XxX2
xxxx na xxxxx xxxxxxxxxxx Xxxxxxx x xxxxxxxxxxxx xxx děti xx
/Xxxxxx xxxxxxxx deposited 3 xxx, x xxxxxxxxxxxx xxxxx xxxxxxx
xx Xxxxxxxx dioxide/° a x xxxxxxxxxxxx xxxxxxxxxxxx do
okolí xxx x xx xxx.
___________________________________________________________________________________________
53 Xxxxxx{2-[2-(xxxxxxxxxxxx- 0,1 % x) xxxxxxxxxx, xxxxx xx oplachují;
noxy)ethoxy]ethyl}di- b) prostřeky, xxxxx xxxxxxxxx xx xxxx, vyjma prostředků
methylamonium-chlorid xxx xxxx x xxxxxx ústní
Benzethonium-chlorid•
BENZETHONIUM CHLORIDE°
___________________________________________________________________________________________
54 Xxxxx(X8 - X18) (benzyl) 0,1 % x xxxxxxxx xx Xxxxxxx xxxxx x očima.
dimethylamonium-chlorid, benzalkonium-chlorid
-bromid a xxx s cukernou
kyselinou (xxxxxxxxxxxx
-xxxxxxx, -xxxxxx x xxx s
cukernou kyselinou)•
/Benzalkonium xxxxxxxx,
xxxxxxx and
saccharinate/°(+)
___________________________________________________________________________________________
55 Xxxxxxxxxxxxxxxx 0,15 % Xxx xxx výrobky, xxxxx xx
(xxxxxxxxxxxxxxxxx)• odstraňují xxxxxxxxxxxx.
/Xxxxxxxxxxxxxxxx/°
___________________________________________________________________________________________
56 3-Xxxxxxx-2-xx-1-xx-X- 0,05 % 1. Nesmí xx xxxxxxxx v Xxxxxxxx xxx.
-xxxxxxxxxxxxx• xxxxxxxxxxxx ústní xxxxxxx x v
/3-Iodo-2-propynyl-butyl- prostředcích x xxxx o xxx.
xxxxxxxxx/° 2. Xxxxx xxxxxxxxxxx x
xxxxxxxxxxxx, které xxxx určeny
k xxxx, xxx zůstávaly na
pokožce, xxxxxxxx 0,02 %,
xxxxxxxx xxxx: Xxxxxxxx jod.
___________________________________________________________________________________________
57 2-methylisothiazol- 0,01 %
-3(2X)-xx•
XXXXXXXXXXXXXXX-
XXXXXX°
___________________________________________________________________________________________
(1) Xxxxx pouze xxx xxxxxxx, které xx mohly xxx xxxxxxx xxx xxxx xx 3 xxx x které xxxxxxxxx x xxxxxxxxxxxx xxxxxxxx x xxxx.
(*) X xxxx xxxxxxx je xxxxx způsobem xxxxxxx xxxxx publikovaný x xxxxxxx mezinárodně xxxxxxxxxxxx xxxxx xxx xxxxxxxxxxxxx xxxxxxx "Computer print-out 1975, International Non-proprietary Xxxxx (XXX) xxx xxxxxxxxxxxxxx xxxxxxxx Lists 1,33 of xxxxxxxx XXX", XXX, Geneva, Xxxxxx 1975.
(•) X xxxx xxxxxxx xx xxxxx způsobem xxxxxxx xxxxx vytvořený xxxxx "Xxxxxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxx XXXXX (Xxxxxxxxxx 1993)", Xxxxxxxx, Xxxxx 2000.
(°) V xxxx xxxxxxx je xxxxx způsobem označen xxxxx x anglickém xxxxxx, xxxxxxxx z xxxxxxxxx "Xxx Cosmetics Xxxxxxxxx 76/768/XXX", Xxxxxx, Xxxxxxxx, Xxxxx 2000.
Xxxx 2
Xxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxx xxxxxxxxxx x xxxxxxxxxxxx prostředcích, xxxxxxxx xxxxxxxxx xxxxxxxxxxx, požadavky xx čistotu xxxxxxxxx xxxxxxxxxxxxx xxxxxx x xxxxxxxx xxxxxxx
_______________________________________________________________________________________
Xxx. xxxxx Xxxxx Xxxxxxxxx Xxxxxxx x Xxxxxxxx xxxxxxx x varování,
povolená xxxxxxxxx xxxxx xxxx být vytištěna xx
xxxxxxxxxxx xxxxx
_______________________________________________________________________________________
x x x x x
_______________________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
Xxxxxxxx: V xxxxxxxx xxxx xxxx xxxxxxx xxxxxxxxxx xxxxxx xxxxx.